Home
Conditions
Respiratory Tract Neoplasms

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,108 public trials 1,858 recruiting studies

Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Not Yet Recruiting

Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels

NCT07360743

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Institut Bergonie Bordeaux Bordeaux, France

APHP-Hôpital Ambroise Paré Boulogne-Billancourt, France

Centre Antoine Lacassagne Nice, France

Institut Gustave Roussy Villejuif, France

View Trial Details

Not Yet Recruiting

Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion

NCT07482605

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +18 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

NCT07625644

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +19 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC

NCT07671092

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +21 more
Locations: Research Facility Christchurch, New Zealand

View Trial Details

Not Yet Recruiting

In Vivo Fluorescence Molecular Bronchoscopy of Durvalumab-680LT in Patients With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) After Chemoradiotherapy

NCT07653438

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1

NCT07450183

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Henry Ford Health Detroit, Michigan, United States

View Trial Details

Not Yet Recruiting

Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)

NCT07680790

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Local Institution - 0212 Beverly Hills, California, United States

Local Institution - 0504 Fullerton, California, United States

Local Institution - 0357 La Jolla, California, United States

Local Institution - 0520 Pueblo, Colorado, United States

View all 200 locations

View Trial Details

Not Yet Recruiting

Two-Point Versus Single-Point Serratus Anterior Plane Block for Post-Thoracoscopic Surgery Analgesia

NCT07700823

Conditions: Lung Cancer, Lung Diseases, Lung Neoplasms, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Pilot Study of the VosCryoTM Breathalyser in Lung Cancer

NCT07689968

Conditions: Advanced Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
Locations: Weston Park Cancer Centre Sheffield, South Yorkshire, United Kingdom

View Trial Details

Not Yet Recruiting

CIMAvax-EGF With KRAS G12C Inhibitor for the Treatment of Advanced, KRAS G12C Mutated Non Small Cell Lung Cancer

NCT07543172

Conditions: Advanced Lung Non-Small Cell Carcinoma, Lung Diseases, Lung Neoplasms, +7 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Respiratory Tract Neoplasms

Respiratory Tract Neoplasms trial results

Related conditions